Adverse Event Management in Patients with Platinum-Resistant Ovarian Cancer Treated with Niraparib and Anlotinib: Updates from the Phase II, Multi-Center ANNIE Study

• Ting DengSun Yat-sen University Cancer Center
• Lei YanFirst Affiliated Hospital of Jinan University
• Jing LiSun Yat-sen University Cancer Center
• Guochen LiuSun Yat-sen University Cancer Center
• Aijun YinShandong University
• Yanling FengSun Yat-sen University Cancer Center
• Min Hua ZhengSun Yat-sen University Cancer Center
• Chuyao ZhangSun Yat-sen University Cancer Center
• He HuangSun Yat-sen University Cancer Center
• Qidan HuangSun Yat-sen University Cancer Center
• Lin AnFujian Provincial Cancer Hospital
• Jie JiangShandong University
• Beihua KongShandong University
• Jihong LiuSun Yat-sen University Cancer Center